Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle

World J Gastroenterol. 2021 Aug 21;27(31):5259-5271. doi: 10.3748/wjg.v27.i31.5259.

Abstract

Background: Various histological types of gastric carcinomas (GCs) differ in terms of their pathogenesis and their preexisting background, both of which could impact the tumor immune microenvironment (TIME). However, the current understanding of the immune contexture of GC is far from complete.

Aim: To clarify the tumor-host immune interplay through histopathological features and the tumor immune cycle concept.

Methods: In total, 50 GC cases were examined (15 cases of diffuse GC, 31 patients with intestinal-type GC and 4 cases of mucinous GC). The immunophenotype of GC was assessed and classified as immune desert (ID), immune excluded (IE) or inflamed (Inf) according to CD8+ cell count and spatial pattern. In addition, CD68+ and CD163+ macrophages and programmed death-ligand 1 (PD-L1) expression were estimated.

Results: We found that GCs with different histological differentiation demonstrated distinct immune contexture. Most intestinal-type GCs had inflamed TIMEs rich in both CD8+ cells and macrophages. In contrast, more aggressive diffuse-type GC more often possessed ID characteristics with few CD8+ lymphocytes but abundant CD68+ macrophages, while mucinous GC had an IE-TIME with a prevalence of CD68+ macrophages and CD8+ lymphocytes in the peritumor stroma. PD-L1 expression prevailed mostly in intestinal-type Inf-GC, with numerous CD163+ cells observed. Therefore, GCs of different histological patterns have specific mechanisms of immune escape. While intestinal-type GC was more often related to PD-L1 expression, diffuse and mucinous GCs possessing more aggressive behavior demonstrated low immunogenicity and a lack of tumor antigen recognition or immune cell recruitment into the tumor clusters.

Conclusion: These data help to clarify the links between tumor histogenesis and immunogenicity for a better understanding of GC biology and more tailored patient management.

Keywords: Gastric carcinoma; Tumor associated macrophages; Tumor immune microenvironment; Tumor infiltrating lymphocytes.

MeSH terms

  • B7-H1 Antigen
  • Carcinoma*
  • Cell Differentiation
  • Humans
  • Lymphocytes, Tumor-Infiltrating
  • Stomach Neoplasms*
  • Tumor Microenvironment

Substances

  • B7-H1 Antigen